Código QR (código de barras bidimensional)

PCSK9 inhibitors for in-hospital treatment of patients with acute coronary syndrome and severe lipid metabolism disorders

Aim. To assess the efficacy and safety of PCSK9 inhibitor alirocumab as part of a combination lipid-lowering therapy in patients with acute coronary syndrome (ACS).Material and methods. This prospective, open-label, single-center activetreatment study included 13 patients hospitalized due to ACS. Th...

Fuld beskrivelse

Na minha lista:
Principais autores: O. L. Barbarash, N. V. Fedorova, D. Yu. Sedykh, O. V. Gruzdeva, O. N. Khryachkova, V. V. Kashtalap, A. A. Filimonova
Format: Artigo
Sprog:Russo
Udgivet: «FIRMA «SILICEA» LLC 2020-09-01
Serier:Российский кардиологический журнал
Fag:
dyslipidemia
acute coronary syndrome
pcsk9 inhibitors
alirocumab
Online adgang:https://russjcardiol.elpub.ru/jour/article/view/4010
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker